SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-086398
Filing Date
2023-08-01
Accepted
2023-08-01 16:31:13
Documents
5
Effectiveness Date
2023-08-01

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2322490d1_s8.htm S-8 55292
2 EXHIBIT 5.1 tm2322490d1_ex5-1.htm EX-5.1 12252
3 EXHIBIT 23.1 tm2322490d1_ex23-1.htm EX-23.1 2471
4 EX-FILING FEES tm2322490d1_ex-filingfees.htm EX-FILING FEES 18594
5 GRAPHIC tm2322490d1_ex5-1img001.jpg GRAPHIC 6259
  Complete submission text file 0001104659-23-086398.txt   98413
Mailing Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-624-1100
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273575 | Film No.: 231132212
SIC: 2834 Pharmaceutical Preparations